Jazz Pharmaceuticals plc‘s (JAZZ) share price has entered into oversold territory with a stochastic value of 10.2848. The Zacks Consensus Estimate on the company’s earnings for December 2012 increased by 1 cent over the past month to $3.79 per share. Jazz Pharmaceuticals plc is a Zacks #2 Rank (” Buy”) company.
To read this article on Zacks.com click here.
Zacks Investment Research
